Upstream Processing

Oct 29, 2015
By BioPharm International Editors
ProBioGen plans to develop and scale-up production of a biosimilar to the mAb cancer drug trastuzumab and will transfer the commercial manufacturing process to Indonesia’s government-owned Bio Farma.
Oct 23, 2015
By BioPharm International Editors
Biovest’s mAbVault provides supply-chain redundancy for antibodies that enables customers to lock in price-per-gram protein production.
Oct 01, 2015
BioPharm International
The author explores the basic rationale and requirements for standardized glycan analysis.
Oct 01, 2015
BioPharm International
Taking immediate steps to address misidentified and contaminated cultured cell lines will improve the reproducibility of preclinical research.
Sep 09, 2015
By BioPharm International Editors
Aragen Bioscience has licensed ProteoNic Biotechnology’s 2G UNic recombinant protein production technology, which increases manufacturing efficiency and reduces cost of goods for recombinant biologicals.
Aug 20, 2015
By BioPharm International Editors
Biopharmaceutical company BeiGene plans to build facility in Suzhou to expand its clinical capability and prepare for commercial manufacturing.
Aug 11, 2015
By BioPharm International Editors
GEA's self-contained homogenizer is designed for laboratory applications, including cell dispersions.
Aug 01, 2015
BioPharm International
A thorough cell-bank testing plan is necessary to certify the safety and purity of a resulting biopharmaceutical product.
Jul 15, 2015
By BioPharm International Editors
The Mobius 2000-L single-use bioreactor from EMD Millipore offers configurable software, hardware, and single-use Flexware assemblies for suspension and adherent cell-culture applications.
Jul 07, 2015
By BioPharm International Editors
Catalent licenses Excelimmune’s antibody combination therapy platform to enable the manufacture of multiple recombinant antibodies in a single batch culture.
native1_300x100
lorem ipsum